-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Tuberous Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Tuberous Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Tuberous Sclerosis Drug Details: LP-352 (AN-352) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Basimglurant in Tuberous Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Basimglurant in Tuberous Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Basimglurant in Tuberous Sclerosis Drug Details: Basimglurant (RG7090, RO4917523, R7090) is under...
-
Product Insights
Tuberous Sclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Tuberous Sclerosis - Drugs In Development, 2023’, provides an overview of the Tuberous Sclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tuberous Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-352 in Tuberous Sclerosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LP-352 in Tuberous Sclerosis Drug Details: LP-352 (AN-352) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cannabidiol in Epileptic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol in Epileptic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cannabidiol in Epileptic Encephalopathy Drug Details: Cannabidiol (Epidiolex , Epidyolex) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol in Opium (Opioid) Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol in Opium (Opioid) Addiction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cannabidiol in Opium (Opioid) Addiction Drug Details: Cannabidiol (Epidiolex , Epidyolex)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Epileptic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Epileptic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Epileptic Encephalopathy Drug Details: LP-352 (AN-352) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Lennox-Gastaut Syndrome Drug Details: LP-352 (AN-352) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Dravet Syndrome (Severe Myoclonic Epilepsy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Soticlestat in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Soticlestat in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Soticlestat in Lennox-Gastaut Syndrome Drug Details: Soticlestat (TAK-935, OV-935) is under development...